导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 20.13% | 224/1050 |
| 近一周 | -1.25% | 507/1104 |
| 近一月 | 0.90% | 75/1103 |
| 近一季 | 1.24% | 237/1092 |
| 近半年 | 14.26% | 212/1070 |
| 近一年 | 36.43% | 141/1018 |
| 近两年 | 80.93% | 305/926 |
| 近三年 | 84.03% | 124/834 |
| 成立以来 | 107.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.24% 323/1070 |
20.09% 387/1101 |
- - |
- - |
| 2025 | 40.20% 324/1065 |
-0.36% 818/1014 |
2.79% 452/1038 |
24.08% 476/1050 |
10.32% 42/1065 |
| 2024 | 9.52% 302/1011 |
6.95% 61/960 |
4.31% 125/983 |
0.28% 953/991 |
-2.09% 459/1011 |
| 2023 | -4.76% 197/952 |
5.50% 290/880 |
-9.51% 751/895 |
-0.39% 99/915 |
0.16% 116/952 |
| 2022 | -27.14% 554/867 |
-7.69% 61/773 |
0.41% 688/806 |
-9.59% 220/845 |
-13.06% 823/867 |
| 2021 | -4.80% 414/740 |
-0.46% 170/580 |
1.50% 521/659 |
-7.40% 434/704 |
1.76% 365/740 |
| 2020 | 35.78% 326/554 |
-3.92% 261/419 |
10.50% 397/466 |
13.13% 176/517 |
13.06% 249/554 |
| 2019 | 55.56% 108/410 |
20.37% 911/1149 |
15.29% 2/1231 |
1.41% 294/390 |
10.53% 149/410 |
| 2018 | -31.24% 234/349 |
- - |
- - |
- - |
-14.68% 865/1080 |
| 2017 | 32.70% 30/285 |
- - |
- - |
- - |
- - |
| 2016 | -3.92% 40/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 前海开源优势蓝筹股票C VS. 东吴新产业精选股票A(580008) |